触发点手法治疗成人慢性非癌性疼痛:系统综述与Meta分析
该系统综述纳入19项随机对照试验共1047例成人慢性非癌性疼痛患者,评估触发点手法治疗(TPMT)的效果。短期疼痛缓解无显著效果(SMD -0.53,95%CI -1.08至0.02),功能改善和患者整体反应有显著获益,但证据质量低,目前不能推荐TPMT。
要点
- TPMT对慢性非癌性疼痛短期缓解无显著效果(SMD -0.53,95%CI -1.08至0.02)。
- TPMT可改善功能(SMD -0.77,95%CI -1.27至-0.26)和患者整体反应(OR 3.79,95%CI 1.86-7.71)。
- 证据质量弱,目前不能推荐TPMT用于慢性非癌性疼痛。
核心结论
- TPMT治疗成人慢性非癌性疼痛的证据弱,目前不能推荐。
研究设计与样本
- 系统综述与Meta分析,检索数据库和临床试验注册库至2017年5月,纳入19项随机对照试验共1047例成人慢性非癌性疼痛患者。
主要发现
- 短期疼痛缓解无显著效果(SMD -0.53,95%CI -1.08至0.02)。
- 一项小样本研究显示长期疼痛获益(SMD -2.00,95%CI -3.40至-0.60),但置信度低。
- 功能有显著改善(SMD -0.77,95%CI -1.27至-0.26)。
- 患者整体反应有显著改善(OR 3.79,95%CI 1.86-7.71,来自4项研究)。
- 健康相关生活质量无显著改善。
关键数值与推荐
- 纳入标准:年龄大于18岁、疼痛持续时间3个月或以上的随机对照试验,任何语言。
- 结局指标:疼痛、功能和患者报告的改善。
- 采用随机效应模型合并数据,使用GRADE评估证据质量。
临床怎么用
- TPMT可考虑用于改善功能和患者整体反应,但需告知患者证据质量弱。
- 不推荐TPMT作为慢性非癌性疼痛的常规治疗。
局限性
- 证据质量弱,置信度低。
- 长期疼痛获益仅来自一项小样本研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To determine the effectiveness of trigger point manual therapy (TPMT) for reducing chronic noncancer pain and associated problems in adults, by analyzing all relevant randomized controlled trials (RCTs). DATA SOURCES: We searched databases and clinical trials registers from their inception to May 2017. STUDY SELECTION: We included RCTs in any language that recruited patients older than 18, with pain of 3 months' duration or more. We assessed pain, function, and patient-reported improvement as outcomes. DATA EXTRACTION: Two authors independently extracted and verified data. Meta-analysis was completed where possible, otherwise data were synthesized narratively. DATA SYNTHESIS: We combined all data using a random-effects model and assessed the quality of evidence using GRADE. A total of 19 trials (involving 1047 participants) met inclusion criteria, representing TPMT treatment of musculoskeletal, pelvic, and facial pain. No effect was found for short-term pain relief (mean standardized difference -0.53; 95% confidence interval [CI], -1.08 to 0.02). One small study showed a longer-term benefit for pain (mean standardized difference -2.00; 95% CI, -3.40 to -0.60) but with low confidence in the effect. Significant gains emerged for function (mean standardized difference -0.77; 95% CI, -1.27 to -0.26) and in patient global response (odds ratio 3.79; 95% CI, 1.86-7.71) from 4 studies, but not for health-related quality of life. CONCLUSIONS: Evidence for TPMT for chronic noncancer pain is weak and it cannot currently be recommended.
引用
- Denneny D, Frawley HC, Petersen K, et al. Trigger Point Manual Therapy for the Treatment of Chronic Noncancer Pain in Adults: A Systematic Review and Meta-analysis. Arch Phys Med Rehabil. 2018. PMID: 30025997. doi:10.1016/j.apmr.2018.06.019
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。